Does KETAMINE Cause Product use in unapproved indication? 457 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 457 reports of Product use in unapproved indication have been filed in association with KETAMINE (KETAMINE HYDROCHLORIDE). This represents 5.7% of all adverse event reports for KETAMINE.
457
Reports of Product use in unapproved indication with KETAMINE
5.7%
of all KETAMINE reports
27
Deaths
97
Hospitalizations
How Dangerous Is Product use in unapproved indication From KETAMINE?
Of the 457 reports, 27 (5.9%) resulted in death, 97 (21.2%) required hospitalization, and 41 (9.0%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for KETAMINE. However, 457 reports have been filed with the FAERS database.
What Other Side Effects Does KETAMINE Cause?
Drug ineffective (1,458)
Off label use (992)
Drug abuse (748)
Anaphylactic shock (568)
Hyperhidrosis (496)
Hypotension (468)
Toxicity to various agents (420)
Sedation (395)
Agitation (344)
Nausea (341)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which KETAMINE Alternatives Have Lower Product use in unapproved indication Risk?
KETAMINE vs KETOCONAZOLE
KETAMINE vs KETOPROFEN
KETAMINE vs KETOPROFEN LYSINE
KETAMINE vs KETOROLAC TROMETHAMINE
KETAMINE vs KETOROLAC\KETOROLAC TROMETHAMINE